2026-2031 Global Immuno-Oncology Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region
This report presents a detailed and holistic analysis of the global Immuno-Oncology market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Immuno-Oncology manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
By Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
By Application
Hospitals
Drugstores
Others
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Immuno-Oncology manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
By Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
By Application
Hospitals
Drugstores
Others
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
- The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
- To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
- Assess the production processes, major issues, and solutions to mitigate the development risk.
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
- Learn about the market strategies that are being adopted by leading respective organizations.
- To understand the future outlook and prospects for the market.
- Besides the standard structure reports, we also provide custom research according to specific requirements.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immuno-Oncology Revenue
1.4 Market Analysis by Type
1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2026-2031
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Cytokine-Based Immunotherapy
1.4.4 Cancer Vaccines
1.4.5 CAR-T Cell Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Immuno-Oncology Market Share by Application: 2026-2031
1.5.2 Hospitals
1.5.3 Drugstores
1.5.4 Others
1.6 Study Objectives
1.7 Overview of Global Immuno-Oncology Market
1.7.1 Global Immuno-Oncology Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Immuno-Oncology
2.2 Industry Chain Structure of Immuno-Oncology
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Immuno-Oncology Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Immuno-Oncology Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Immuno-Oncology Average Price by Manufacturers (2020-2025)
4 IMMUNO-ONCOLOGY REGIONAL MARKET ANALYSIS
4.1 Immuno-Oncology Production by Regions
4.1.1 Global Immuno-Oncology Production by Regions (2020-2025)
4.1.2 Global Immuno-Oncology Revenue by Regions
4.2 Immuno-Oncology Consumption by Regions
4.3 North America Immuno-Oncology Market Analysis
4.3.1 North America Immuno-Oncology Production
4.3.2 North America Immuno-Oncology Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Immuno-Oncology Import and Export
4.4 East Asia Immuno-Oncology Market Analysis
4.4.1 East Asia Immuno-Oncology Production
4.4.2 East Asia Immuno-Oncology Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Immuno-Oncology Import & Export
4.5 Europe Immuno-Oncology Market Analysis
4.5.1 Europe Immuno-Oncology Production
4.5.2 Europe Immuno-Oncology Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Immuno-Oncology Import & Export
4.6 South Asia Immuno-Oncology Market Analysis
4.6.1 South Asia Immuno-Oncology Production
4.6.2 South Asia Immuno-Oncology Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Immuno-Oncology Import & Export
4.7 Southeast Asia Immuno-Oncology Market Analysis
4.7.1 Southeast Asia Immuno-Oncology Production
4.7.2 Southeast Asia Immuno-Oncology Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Immuno-Oncology Import & Export
4.8 Middle East Immuno-Oncology Market Analysis
4.8.1 Middle East Immuno-Oncology Production
4.8.2 Middle East Immuno-Oncology Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Immuno-Oncology Import & Export
4.9 Africa Immuno-Oncology Market Analysis
4.9.1 Africa Immuno-Oncology Production
4.9.2 Africa Immuno-Oncology Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Immuno-Oncology Import & Export
4.10 Oceania Immuno-Oncology Market Analysis
4.10.1 Oceania Immuno-Oncology Production
4.10.2 Oceania Immuno-Oncology Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Immuno-Oncology Import & Export
4.11 South America Immuno-Oncology Market Analysis
4.11.1 South America Immuno-Oncology Production
4.11.2 South America Immuno-Oncology Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Immuno-Oncology Import & Export
5 IMMUNO-ONCOLOGY SALES MARKET BY TYPE (2020-2031)
5.1 Global Immuno-Oncology Historic Market Size by Type (2020-2025)
5.2 Global Immuno-Oncology Forecasted Market Size by Type (2026-2031)
6 IMMUNO-ONCOLOGY CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Immuno-Oncology Historic Market Size by Application (2020-2025)
6.2 Global Immuno-Oncology Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN IMMUNO-ONCOLOGY BUSINESS
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Profile
7.1.2 Bristol-Myers Squibb Immuno-Oncology Product Specification
7.1.3 Bristol-Myers Squibb Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Profile
7.2.2 Merck & Co., Inc. Immuno-Oncology Product Specification
7.2.3 Merck & Co., Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Roche AG
7.3.1 Roche AG Company Profile
7.3.2 Roche AG Immuno-Oncology Product Specification
7.3.3 Roche AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 AstraZeneca, Plc
7.4.1 AstraZeneca, Plc Company Profile
7.4.2 AstraZeneca, Plc Immuno-Oncology Product Specification
7.4.3 AstraZeneca, Plc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Profile
7.5.2 Sanofi S.A. Immuno-Oncology Product Specification
7.5.3 Sanofi S.A. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Company Profile
7.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Specification
7.6.3 Dendreon Pharmaceuticals Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Novartis
7.7.1 Novartis Company Profile
7.7.2 Novartis Immuno-Oncology Product Specification
7.7.3 Novartis Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Company Profile
7.8.2 Gilead Sciences Inc. Immuno-Oncology Product Specification
7.8.3 Gilead Sciences Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Merck KGaA
7.9.1 Merck KGaA Company Profile
7.9.2 Merck KGaA Immuno-Oncology Product Specification
7.9.3 Merck KGaA Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Immuno-Oncology (2026-2031)
8.2 Global Forecasted Revenue of Immuno-Oncology (2026-2031)
8.3 Global Forecasted Price of Immuno-Oncology (2020-2031)
8.4 Global Forecasted Production of Immuno-Oncology by Region (2026-2031)
8.4.1 North America Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.3 Europe Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.7 Africa Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.9 South America Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Immuno-Oncology by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Immuno-Oncology by Country
9.2 East Asia Market Forecasted Consumption of Immuno-Oncology by Country
9.3 Europe Market Forecasted Consumption of Immuno-Oncology by Countriy
9.4 South Asia Forecasted Consumption of Immuno-Oncology by Country
9.5 Southeast Asia Forecasted Consumption of Immuno-Oncology by Country
9.6 Middle East Forecasted Consumption of Immuno-Oncology by Country
9.7 Africa Forecasted Consumption of Immuno-Oncology by Country
9.8 Oceania Forecasted Consumption of Immuno-Oncology by Country
9.9 South America Forecasted Consumption of Immuno-Oncology by Country
9.10 Rest of the world Forecasted Consumption of Immuno-Oncology by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immuno-Oncology Revenue
1.4 Market Analysis by Type
1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2026-2031
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Cytokine-Based Immunotherapy
1.4.4 Cancer Vaccines
1.4.5 CAR-T Cell Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Immuno-Oncology Market Share by Application: 2026-2031
1.5.2 Hospitals
1.5.3 Drugstores
1.5.4 Others
1.6 Study Objectives
1.7 Overview of Global Immuno-Oncology Market
1.7.1 Global Immuno-Oncology Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Immuno-Oncology
2.2 Industry Chain Structure of Immuno-Oncology
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Immuno-Oncology Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Immuno-Oncology Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Immuno-Oncology Average Price by Manufacturers (2020-2025)
4 IMMUNO-ONCOLOGY REGIONAL MARKET ANALYSIS
4.1 Immuno-Oncology Production by Regions
4.1.1 Global Immuno-Oncology Production by Regions (2020-2025)
4.1.2 Global Immuno-Oncology Revenue by Regions
4.2 Immuno-Oncology Consumption by Regions
4.3 North America Immuno-Oncology Market Analysis
4.3.1 North America Immuno-Oncology Production
4.3.2 North America Immuno-Oncology Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Immuno-Oncology Import and Export
4.4 East Asia Immuno-Oncology Market Analysis
4.4.1 East Asia Immuno-Oncology Production
4.4.2 East Asia Immuno-Oncology Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Immuno-Oncology Import & Export
4.5 Europe Immuno-Oncology Market Analysis
4.5.1 Europe Immuno-Oncology Production
4.5.2 Europe Immuno-Oncology Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Immuno-Oncology Import & Export
4.6 South Asia Immuno-Oncology Market Analysis
4.6.1 South Asia Immuno-Oncology Production
4.6.2 South Asia Immuno-Oncology Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Immuno-Oncology Import & Export
4.7 Southeast Asia Immuno-Oncology Market Analysis
4.7.1 Southeast Asia Immuno-Oncology Production
4.7.2 Southeast Asia Immuno-Oncology Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Immuno-Oncology Import & Export
4.8 Middle East Immuno-Oncology Market Analysis
4.8.1 Middle East Immuno-Oncology Production
4.8.2 Middle East Immuno-Oncology Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Immuno-Oncology Import & Export
4.9 Africa Immuno-Oncology Market Analysis
4.9.1 Africa Immuno-Oncology Production
4.9.2 Africa Immuno-Oncology Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Immuno-Oncology Import & Export
4.10 Oceania Immuno-Oncology Market Analysis
4.10.1 Oceania Immuno-Oncology Production
4.10.2 Oceania Immuno-Oncology Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Immuno-Oncology Import & Export
4.11 South America Immuno-Oncology Market Analysis
4.11.1 South America Immuno-Oncology Production
4.11.2 South America Immuno-Oncology Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Immuno-Oncology Import & Export
5 IMMUNO-ONCOLOGY SALES MARKET BY TYPE (2020-2031)
5.1 Global Immuno-Oncology Historic Market Size by Type (2020-2025)
5.2 Global Immuno-Oncology Forecasted Market Size by Type (2026-2031)
6 IMMUNO-ONCOLOGY CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Immuno-Oncology Historic Market Size by Application (2020-2025)
6.2 Global Immuno-Oncology Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN IMMUNO-ONCOLOGY BUSINESS
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Profile
7.1.2 Bristol-Myers Squibb Immuno-Oncology Product Specification
7.1.3 Bristol-Myers Squibb Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Profile
7.2.2 Merck & Co., Inc. Immuno-Oncology Product Specification
7.2.3 Merck & Co., Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Roche AG
7.3.1 Roche AG Company Profile
7.3.2 Roche AG Immuno-Oncology Product Specification
7.3.3 Roche AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 AstraZeneca, Plc
7.4.1 AstraZeneca, Plc Company Profile
7.4.2 AstraZeneca, Plc Immuno-Oncology Product Specification
7.4.3 AstraZeneca, Plc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Profile
7.5.2 Sanofi S.A. Immuno-Oncology Product Specification
7.5.3 Sanofi S.A. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Company Profile
7.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Specification
7.6.3 Dendreon Pharmaceuticals Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Novartis
7.7.1 Novartis Company Profile
7.7.2 Novartis Immuno-Oncology Product Specification
7.7.3 Novartis Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Company Profile
7.8.2 Gilead Sciences Inc. Immuno-Oncology Product Specification
7.8.3 Gilead Sciences Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Merck KGaA
7.9.1 Merck KGaA Company Profile
7.9.2 Merck KGaA Immuno-Oncology Product Specification
7.9.3 Merck KGaA Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Immuno-Oncology (2026-2031)
8.2 Global Forecasted Revenue of Immuno-Oncology (2026-2031)
8.3 Global Forecasted Price of Immuno-Oncology (2020-2031)
8.4 Global Forecasted Production of Immuno-Oncology by Region (2026-2031)
8.4.1 North America Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.3 Europe Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.7 Africa Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.9 South America Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Immuno-Oncology Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Immuno-Oncology by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Immuno-Oncology by Country
9.2 East Asia Market Forecasted Consumption of Immuno-Oncology by Country
9.3 Europe Market Forecasted Consumption of Immuno-Oncology by Countriy
9.4 South Asia Forecasted Consumption of Immuno-Oncology by Country
9.5 Southeast Asia Forecasted Consumption of Immuno-Oncology by Country
9.6 Middle East Forecasted Consumption of Immuno-Oncology by Country
9.7 Africa Forecasted Consumption of Immuno-Oncology by Country
9.8 Oceania Forecasted Consumption of Immuno-Oncology by Country
9.9 South America Forecasted Consumption of Immuno-Oncology by Country
9.10 Rest of the world Forecasted Consumption of Immuno-Oncology by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES
Key Players Covered: Ranking by Immuno-Oncology Revenue 2020-2025
Global Immuno-Oncology Market Size by Type: 2026-2031
Global Immuno-Oncology Market Size by Application: 2026-2031
Immuno-Oncology Production Rank and Commercial Production Date of Key Manufacturers
Global Immuno-Oncology Manufacturing Plants Distribution and Commercial Production Date
Global Immuno-Oncology Production Capacity by Manufacturers
Global Immuno-Oncology Production by Manufacturers (2020-2025)
Global Immuno-Oncology Production Market Share by Manufacturers (2020-2025)
Global Immuno-Oncology Revenue by Manufacturers (2020-2025)
Global Immuno-Oncology Revenue Share by Manufacturers (2020-2025)
Global Market Immuno-Oncology Average Price of Key Manufacturers (2020-2025)
Manufacturers Immuno-Oncology Production Sites and Area Served
Manufacturers Immuno-Oncology Product Type
Global Immuno-Oncology Production by Regions (2020-2025)
Global Immuno-Oncology Production Market Share by Regions (2020-2025)
Global Immuno-Oncology Revenue by Regions (2020-2025)
Global Immuno-Oncology Revenue Market Share by Regions (2020-2025)
Global Immuno-Oncology Consumption by Regions (2020-2025)
Global Immuno-Oncology Consumption Market Share by Regions (2020-2025)
Key Immuno-Oncology Players Sales Volume in North America
North America Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in East Asia
East Asia Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Europe
Europe Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in South Asia
South Asia Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Southeast Asia
Southeast Asia Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Middle East
Middle East Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Africa
Africa Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Oceania
Oceania Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in South America
South America Immuno-Oncology Production, Consumption Import and Export
Global Immuno-Oncology Market Size by Type (2020-2025)
Global Immuno-Oncology Revenue Market Share by Type (2020-2025)
Global Immuno-Oncology Forecasted Market Size by Type (2026-2031)
Global Immuno-Oncology Revenue Market Share by Type (2026-2031)
Global Immuno-Oncology Market Size by Application (2020-2025)
Global Immuno-Oncology Revenue Market Share by Application (2020-2025)
Global Immuno-Oncology Forecasted Market Size by Application (2026-2031)
Global Immuno-Oncology Revenue Market Share by Application (2026-2031)
Bristol-Myers Squibb Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Merck & Co., Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Roche AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table AstraZeneca, Plc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Sanofi S.A. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Dendreon Pharmaceuticals Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Novartis Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Gilead Sciences Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Merck KGaA Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Immuno-Oncology Production Forecast by Region (2026-2031)
Global Immuno-Oncology Sales Volume Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Volume Market Share Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Revenue Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Revenue Market Share Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Price Forecast by Type (2026-2031)
Global Immuno-Oncology Consumption Volume Forecast by Application (2026-2031)
Global Immuno-Oncology Consumption Value Forecast by Application (2026-2031)
North America Immuno-Oncology Consumption Forecast 2026-2031 by Country
East Asia Immuno-Oncology Consumption Forecast 2026-2031 by Country
Europe Immuno-Oncology Consumption Forecast 2026-2031 by Country
South Asia Immuno-Oncology Consumption Forecast 2026-2031 by Country
Southeast Asia Immuno-Oncology Consumption Forecast 2026-2031 by Country
Middle East Immuno-Oncology Consumption Forecast 2026-2031 by Country
Africa Immuno-Oncology Consumption Forecast 2026-2031 by Country
Oceania Immuno-Oncology Consumption Forecast 2026-2031 by Country
South America Immuno-Oncology Consumption Forecast 2026-2031 by Country
Rest of the world Immuno-Oncology Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Immuno-Oncology Market Share by Type: 2025 VS 2031
Immune Checkpoint Inhibitors Features
Cytokine-Based Immunotherapy Features
Cancer Vaccines Features
CAR-T Cell Therapy Features
Others Features
Global Immuno-Oncology Market Share by Application: 2025 VS 2031
Hospitals Case Studies
Drugstores Case Studies
Others Case Studies
Immuno-Oncology Report Years Considered
Global Immuno-Oncology Market Status and Outlook (2020-2031)
North America Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
East Asia Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Europe Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
South Asia Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
South America Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Middle East Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Africa Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Oceania Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
South America Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Global Immuno-Oncology Revenue (2020-2031)
Global Immuno-Oncology Production Capacity (2020-2031)
Global Immuno-Oncology Production (2020-2031)
Manufacturing Cost Structure Analysis of Immuno-Oncology in 2025
Manufacturing Process Analysis of Immuno-Oncology
Industry Chain Structure of Immuno-Oncology
Global Immuno-Oncology Production Market Share by Regions in 2025
Global Immuno-Oncology Revenue Market Share by Regions in 2025
North America Immuno-Oncology Production Growth Rate 2020-2025
North America Immuno-Oncology Revenue Growth Rate 2020-2025
East Asia Immuno-Oncology Production Growth Rate 2020-2025
East Asia Immuno-Oncology Revenue Growth Rate 2020-2025
Europe Immuno-Oncology Production Growth Rate 2020-2025
Europe Immuno-Oncology Revenue Growth Rate 2020-2025
South Asia Immuno-Oncology Production Growth Rate 2020-2025
South Asia Immuno-Oncology Revenue Growth Rate 2020-2025
Southeast Asia Immuno-Oncology Production Growth Rate 2020-2025
Southeast Asia Immuno-Oncology Revenue Growth Rate 2020-2025
Middle East Immuno-Oncology Production Growth Rate 2020-2025
Middle East Immuno-Oncology Revenue Growth Rate 2020-2025
Africa Immuno-Oncology Production Growth Rate 2020-2025
Africa Immuno-Oncology Revenue Growth Rate 2020-2025
Oceania Immuno-Oncology Production Growth Rate 2020-2025
Oceania Immuno-Oncology Revenue Growth Rate 2020-2025
South America Immuno-Oncology Production Growth Rate 2020-2025
South America Immuno-Oncology Revenue Growth Rate 2020-2025
Bristol-Myers Squibb Immuno-Oncology Product Specification
Merck & Co., Inc. Immuno-Oncology Product Specification
Roche AG Immuno-Oncology Product Specification
AstraZeneca, Plc Immuno-Oncology Product Specification
Sanofi S.A. Immuno-Oncology Product Specification
Dendreon Pharmaceuticals Immuno-Oncology Product Specification
Novartis Immuno-Oncology Product Specification
Gilead Sciences Inc. Immuno-Oncology Product Specification
Merck KGaA Immuno-Oncology Product Specification
Global Immuno-Oncology Production Capacity Growth Rate Forecast (2026-2031)
Global Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Global Immuno-Oncology Price and Trend Forecast (2020-2031)
North America Immuno-Oncology Production Growth Rate Forecast (2026-2031)
North America Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
East Asia Immuno-Oncology Production Growth Rate Forecast (2026-2031)
East Asia Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Europe Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Europe Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
South Asia Immuno-Oncology Production Growth Rate Forecast (2026-2031)
South Asia Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Southeast Asia Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Middle East Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Middle East Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Africa Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Africa Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Oceania Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Oceania Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
South America Immuno-Oncology Production Growth Rate Forecast (2026-2031)
South America Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Rest of the World Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Rest of the World Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
North America Immuno-Oncology Consumption Forecast 2026-2031
East Asia Immuno-Oncology Consumption Forecast 2026-2031
Europe Immuno-Oncology Consumption Forecast 2026-2031
South Asia Immuno-Oncology Consumption Forecast 2026-2031
Southeast Asia Immuno-Oncology Consumption Forecast 2026-2031
Middle East Immuno-Oncology Consumption Forecast 2026-2031
Africa Immuno-Oncology Consumption Forecast 2026-2031
Oceania Immuno-Oncology Consumption Forecast 2026-2031
South America Immuno-Oncology Consumption Forecast 2026-2031
Rest of the world Immuno-Oncology Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
Key Players Covered: Ranking by Immuno-Oncology Revenue 2020-2025
Global Immuno-Oncology Market Size by Type: 2026-2031
Global Immuno-Oncology Market Size by Application: 2026-2031
Immuno-Oncology Production Rank and Commercial Production Date of Key Manufacturers
Global Immuno-Oncology Manufacturing Plants Distribution and Commercial Production Date
Global Immuno-Oncology Production Capacity by Manufacturers
Global Immuno-Oncology Production by Manufacturers (2020-2025)
Global Immuno-Oncology Production Market Share by Manufacturers (2020-2025)
Global Immuno-Oncology Revenue by Manufacturers (2020-2025)
Global Immuno-Oncology Revenue Share by Manufacturers (2020-2025)
Global Market Immuno-Oncology Average Price of Key Manufacturers (2020-2025)
Manufacturers Immuno-Oncology Production Sites and Area Served
Manufacturers Immuno-Oncology Product Type
Global Immuno-Oncology Production by Regions (2020-2025)
Global Immuno-Oncology Production Market Share by Regions (2020-2025)
Global Immuno-Oncology Revenue by Regions (2020-2025)
Global Immuno-Oncology Revenue Market Share by Regions (2020-2025)
Global Immuno-Oncology Consumption by Regions (2020-2025)
Global Immuno-Oncology Consumption Market Share by Regions (2020-2025)
Key Immuno-Oncology Players Sales Volume in North America
North America Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in East Asia
East Asia Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Europe
Europe Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in South Asia
South Asia Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Southeast Asia
Southeast Asia Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Middle East
Middle East Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Africa
Africa Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in Oceania
Oceania Immuno-Oncology Production, Consumption Import and Export
Key Immuno-Oncology Players Sales Volume in South America
South America Immuno-Oncology Production, Consumption Import and Export
Global Immuno-Oncology Market Size by Type (2020-2025)
Global Immuno-Oncology Revenue Market Share by Type (2020-2025)
Global Immuno-Oncology Forecasted Market Size by Type (2026-2031)
Global Immuno-Oncology Revenue Market Share by Type (2026-2031)
Global Immuno-Oncology Market Size by Application (2020-2025)
Global Immuno-Oncology Revenue Market Share by Application (2020-2025)
Global Immuno-Oncology Forecasted Market Size by Application (2026-2031)
Global Immuno-Oncology Revenue Market Share by Application (2026-2031)
Bristol-Myers Squibb Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Merck & Co., Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Roche AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table AstraZeneca, Plc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Sanofi S.A. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Dendreon Pharmaceuticals Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Novartis Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Gilead Sciences Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Merck KGaA Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Immuno-Oncology Production Forecast by Region (2026-2031)
Global Immuno-Oncology Sales Volume Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Volume Market Share Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Revenue Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Revenue Market Share Forecast by Type (2026-2031)
Global Immuno-Oncology Sales Price Forecast by Type (2026-2031)
Global Immuno-Oncology Consumption Volume Forecast by Application (2026-2031)
Global Immuno-Oncology Consumption Value Forecast by Application (2026-2031)
North America Immuno-Oncology Consumption Forecast 2026-2031 by Country
East Asia Immuno-Oncology Consumption Forecast 2026-2031 by Country
Europe Immuno-Oncology Consumption Forecast 2026-2031 by Country
South Asia Immuno-Oncology Consumption Forecast 2026-2031 by Country
Southeast Asia Immuno-Oncology Consumption Forecast 2026-2031 by Country
Middle East Immuno-Oncology Consumption Forecast 2026-2031 by Country
Africa Immuno-Oncology Consumption Forecast 2026-2031 by Country
Oceania Immuno-Oncology Consumption Forecast 2026-2031 by Country
South America Immuno-Oncology Consumption Forecast 2026-2031 by Country
Rest of the world Immuno-Oncology Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Immuno-Oncology Market Share by Type: 2025 VS 2031
Immune Checkpoint Inhibitors Features
Cytokine-Based Immunotherapy Features
Cancer Vaccines Features
CAR-T Cell Therapy Features
Others Features
Global Immuno-Oncology Market Share by Application: 2025 VS 2031
Hospitals Case Studies
Drugstores Case Studies
Others Case Studies
Immuno-Oncology Report Years Considered
Global Immuno-Oncology Market Status and Outlook (2020-2031)
North America Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
East Asia Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Europe Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
South Asia Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
South America Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Middle East Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Africa Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Oceania Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
South America Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Immuno-Oncology Revenue (Value) and Growth Rate (2020-2031)
Global Immuno-Oncology Revenue (2020-2031)
Global Immuno-Oncology Production Capacity (2020-2031)
Global Immuno-Oncology Production (2020-2031)
Manufacturing Cost Structure Analysis of Immuno-Oncology in 2025
Manufacturing Process Analysis of Immuno-Oncology
Industry Chain Structure of Immuno-Oncology
Global Immuno-Oncology Production Market Share by Regions in 2025
Global Immuno-Oncology Revenue Market Share by Regions in 2025
North America Immuno-Oncology Production Growth Rate 2020-2025
North America Immuno-Oncology Revenue Growth Rate 2020-2025
East Asia Immuno-Oncology Production Growth Rate 2020-2025
East Asia Immuno-Oncology Revenue Growth Rate 2020-2025
Europe Immuno-Oncology Production Growth Rate 2020-2025
Europe Immuno-Oncology Revenue Growth Rate 2020-2025
South Asia Immuno-Oncology Production Growth Rate 2020-2025
South Asia Immuno-Oncology Revenue Growth Rate 2020-2025
Southeast Asia Immuno-Oncology Production Growth Rate 2020-2025
Southeast Asia Immuno-Oncology Revenue Growth Rate 2020-2025
Middle East Immuno-Oncology Production Growth Rate 2020-2025
Middle East Immuno-Oncology Revenue Growth Rate 2020-2025
Africa Immuno-Oncology Production Growth Rate 2020-2025
Africa Immuno-Oncology Revenue Growth Rate 2020-2025
Oceania Immuno-Oncology Production Growth Rate 2020-2025
Oceania Immuno-Oncology Revenue Growth Rate 2020-2025
South America Immuno-Oncology Production Growth Rate 2020-2025
South America Immuno-Oncology Revenue Growth Rate 2020-2025
Bristol-Myers Squibb Immuno-Oncology Product Specification
Merck & Co., Inc. Immuno-Oncology Product Specification
Roche AG Immuno-Oncology Product Specification
AstraZeneca, Plc Immuno-Oncology Product Specification
Sanofi S.A. Immuno-Oncology Product Specification
Dendreon Pharmaceuticals Immuno-Oncology Product Specification
Novartis Immuno-Oncology Product Specification
Gilead Sciences Inc. Immuno-Oncology Product Specification
Merck KGaA Immuno-Oncology Product Specification
Global Immuno-Oncology Production Capacity Growth Rate Forecast (2026-2031)
Global Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Global Immuno-Oncology Price and Trend Forecast (2020-2031)
North America Immuno-Oncology Production Growth Rate Forecast (2026-2031)
North America Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
East Asia Immuno-Oncology Production Growth Rate Forecast (2026-2031)
East Asia Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Europe Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Europe Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
South Asia Immuno-Oncology Production Growth Rate Forecast (2026-2031)
South Asia Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Southeast Asia Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Middle East Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Middle East Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Africa Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Africa Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Oceania Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Oceania Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
South America Immuno-Oncology Production Growth Rate Forecast (2026-2031)
South America Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
Rest of the World Immuno-Oncology Production Growth Rate Forecast (2026-2031)
Rest of the World Immuno-Oncology Revenue Growth Rate Forecast (2026-2031)
North America Immuno-Oncology Consumption Forecast 2026-2031
East Asia Immuno-Oncology Consumption Forecast 2026-2031
Europe Immuno-Oncology Consumption Forecast 2026-2031
South Asia Immuno-Oncology Consumption Forecast 2026-2031
Southeast Asia Immuno-Oncology Consumption Forecast 2026-2031
Middle East Immuno-Oncology Consumption Forecast 2026-2031
Africa Immuno-Oncology Consumption Forecast 2026-2031
Oceania Immuno-Oncology Consumption Forecast 2026-2031
South America Immuno-Oncology Consumption Forecast 2026-2031
Rest of the world Immuno-Oncology Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
